No. 1285 The human leukaemia virus HTLV-1: regulation of latency in vivo
| Date: | Apr. 06, 2018 15:00 - 16:00 |
|---|---|
| Room: | Kyoto University Seminar Room, 1st Floor, Bldg. #2 of Institute for Frontier Life and Medical Sciences |
| Speaker: | Dr. Charles R M Bangham Imperial College London |
| Title: | The human leukaemia virus HTLV-1: regulation of latency in vivo |
Abstract
The human leukaemia virus HTLV-1 persists lifelong in infected people. Although the virus elicits a strong chronically activated T cell immune response to the major viral proteins Gag, Pol, Env and Tax, the genes encoding these proteins are usually silent in circulating lymphocytes. In contrast, there is a weak T cell response to the viral protein HBZ, which appears to be persistently expressed at a low level.
There is recent evidence that the plus strand of the HTLV-1 provirus, which encodes the immunodominant T cell antigens, is expressed in intermittent bursts, whereas the minus strand (encoding hbz) is almost constantly expressed, in all cells, at a low level. We are now investigating how HTLV-1 regulates this selective expression of the proviral plus- and minus-strands. I shall present evidence from single molecule RNA-FISH, chromosome conformation capture, small-molecule inhibitors, and transcription analysis (RNA-Seq; qRT-PCR) that specific epigenetic and metabolic factors regulate this strand-specific proviral expression. The results offer an explanation of long-standing paradoxes and unexplained observations in the biology of this pathogenic retrovirus.
| Invitator | Masao Matsuoka, Junichiro Yasunaga |
| Lab. of Virus Control (TEL: 751-4048 ) |